Bolt Biotherapeutics Funding & Investors
Redwood City, CA
Bolt Biotherapeutics, Inc. operates as a biotechnology company. The Company develops immune-stimulating antibody conjugates, a new class of cancer therapeutics, which systemically-administered and uncover the immune system to induce anti-tumor immunity. Bolt Biotherapeutics serves healthcare industry in the United States.
boltbio.comTotal Amount Raised: $198,500,000
Bolt Biotherapeutics Funding Rounds
Post Ipo Equity
$15,000,000
Post Ipo Equity Investors
GenmabIPO
Unknown
Series C
$93,500,000
Series C Investors
Sofinnova InvestmentsRock Springs CapitalRa Capital ManagementNovo HoldingsPivotal bioVenture PartnersSurveyor CapitalVivo CapitalPfizer Venture InvestmentsSamsara BioCapitalSeries B
$54,000,000
Series B Investors
Pivotal bioVenture PartnersNan Fung Life SciencesNovo HoldingsVivo CapitalSeries B
$54,000,000
Series B Investors
Pivotal bioVenture PartnersNan Fung Life SciencesNovo HoldingsVivo CapitalSeries Unknown
$19,400,000
Series Unknown
$6,000,002
Series Unknown
$9,999,998
Seed
$600,000
Funding info provided by Diffbot.